449 related articles for article (PubMed ID: 16377851)
1. Antiretroviral drug resistance and resistance testing.
Gallant JE
Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
[TBL] [Abstract][Full Text] [Related]
2. Genotypic resistance tests for the clinical management of patients with primary HIV infection.
Narciso P; Lazzarin A
Scand J Infect Dis Suppl; 2003; 106():66-70. PubMed ID: 15000588
[TBL] [Abstract][Full Text] [Related]
3. Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.
Montroni M; Monforte AD
Scand J Infect Dis Suppl; 2003; 106():79-81. PubMed ID: 15000591
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.
Hanna GJ; D'Aquila RT
Clin Infect Dis; 2001 Mar; 32(5):774-82. PubMed ID: 11229846
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
6. Genotypic resistance tests in the management of the HIV-infected patient at virological failure.
Aceti A; Carosi G
Scand J Infect Dis Suppl; 2003; 106():61-6. PubMed ID: 15000587
[TBL] [Abstract][Full Text] [Related]
7. Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance.
Sukasem C; Churdboonchart V; Sirisidthi K; Riengrojpitak S; Chasombat S; Watitpun C; Piroj W; Tiensuwan M; Chantratita W
Jpn J Infect Dis; 2007 Sep; 60(5):284-9. PubMed ID: 17881868
[TBL] [Abstract][Full Text] [Related]
8. HIV resistance testing. A clinical tool.
Paul SM; Jorden VS
N J Med; 2003 Sep; 100(9 Suppl):44-9; quiz 75-6. PubMed ID: 14556603
[TBL] [Abstract][Full Text] [Related]
9. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
[TBL] [Abstract][Full Text] [Related]
10. Your next nightmare: 28% of new HIV cases may be drug-resistant.
AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off?
Simcock M; Sendi P; Ledergerber B; Keller T; Schüpbach J; Battegay M; Günthard HF;
Antivir Ther; 2006; 11(3):305-14. PubMed ID: 16759046
[TBL] [Abstract][Full Text] [Related]
12. Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
Vercauteren J; Vandamme AM
Antiviral Res; 2006 Sep; 71(2-3):335-42. PubMed ID: 16782210
[TBL] [Abstract][Full Text] [Related]
13. The use of resistance testing in the management of HIV-1-infected patients.
Grant PM; Zolopa AR
Curr Opin HIV AIDS; 2009 Nov; 4(6):474-80. PubMed ID: 20048713
[TBL] [Abstract][Full Text] [Related]
14. Testing for HIV-1 drug resistance.
Hanna GJ; Caliendo AM
Mol Diagn; 2001 Dec; 6(4):253-63. PubMed ID: 11774191
[TBL] [Abstract][Full Text] [Related]
15. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.
Gonsalez CR; Alcalde R; Nishiya A; Barreto CC; Silva FE; de Almeida A; Mendonça M; Ferreira F; Fernandes SS; Casseb J; Duarte AJ
Virus Res; 2007 Nov; 129(2):87-90. PubMed ID: 17686543
[TBL] [Abstract][Full Text] [Related]
17. Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.
Liuzzi G
Scand J Infect Dis Suppl; 2003; 106():90-3. PubMed ID: 15000595
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV-1-infected patients with virological failure.
Llibre JM; Schapiro JM; Clotet B
Clin Infect Dis; 2010 Mar; 50(6):872-81. PubMed ID: 20158400
[TBL] [Abstract][Full Text] [Related]
19. Resistance testing debate: does it make the grade?
Simmons P
Res Initiat Treat Action; 1999 Oct; 5(4):9-12. PubMed ID: 11366943
[TBL] [Abstract][Full Text] [Related]
20. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
